直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • News
  • Finnegan Facts
  • History
    • Finnegan VISION
    • Finnegan FORWARD
  • Pro Bono
  • Management
    • Pricing & Alternative Fee Arrangements
    • AFA Models We Offer
    • Contingency Fees
    • AI + KM

Media Mention

Biologic Patents Need Specific Claim Parameters After Prometheus Case

July 23, 2012

The Pink Sheet

On a July 17 seminar on intellectual property sponsored by the Food and Drug Law Institute, Finnegan partner Richard B. Racine, spoke to how patent examiners can build a better patent.  “Number one, you have a claim process – if you don’t have a claim process, forget about it. Two, does the claim focus on a law of nature or a law of nature principle? So if those first two apply, then it says, does the claim include additional elements, steps … and is [it] practically applied? So, they say the claim must include additional elements or steps so that the inventor has practically applied or added something to the natural principle itself. So some integration of the steps beyond just looking at some natural principle.”  This implies that innovator companies seeking such patents should not be “applying conventional steps to the natural principle, like adding up stuff or measuring things, providing instructions or suing a machine just in a routine way that doesn’t add anything, he added.”  Mr. Racine also discussed specific claim parameters and biologics.

Related Practices

Global IP Enforcement, Litigation, and Trials

Prosecution and Portfolio Management

Related Industries

Life Sciences

Pharmaceutical

Related Professionals

Richard B. Racine
Senior Counsel
Washington, DC
+1 202 408 4038
Email

Related News

Commentary

UK Patent Document Access Rules Raise Secrecy Concerns

August 12, 2026

Commentary

GenAI Patent Surge Extends Well Beyond Familiar Platform Firms

August 10, 2026

Commentary

Q&A: What the 'GenAI Boom' Means for Patents

August 6, 2026

Commentary

A Win in Every Forum: Judge Terminates Zync's Case Against BMW

July 30, 2026

Commentary

Forum Clause Dooms ITC Trade Secret Case Against BMW

July 29, 2026

Commentary

AI Patent Surge Signals Broader Global and Industrial Reach

July 23, 2026

Commentary

Generative AI Patents Booming Globally, World IP Org. Reports

July 17, 2026

Award/Ranking

Finnegan Shortlisted in 13 Categories at the 2026 LMG Life Sciences America Awards

July 15, 2026

Commentary

PTAB Filings Down 81% in Q2 2026 as Patent Challengers Abandon IPR Playbook

July 13, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP